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Inhibitor of DNA synthesis, is a soluble, protein lym-
phocyte factor which nonspecifically suppresses in vitro 
lymphocyte responses to antigens or mitogens. It is se-
creted in large amounts in vivo in some experimentally 
induced immunological paralysis. Here, we have defined 
the cell secreting IDS in one experimental model of non-
specific immune-suppression, ie., that of antigenic com-
petition. 
Lymphocytes of rats injected with a large dose of 
ovalbumin intravenously, show no immunologic re-
sponse to the same or other antigens or mitogens 24 hr 
later. At this time, spleen cells of these rats secrete large 
amounts of the inhibitor into culture supernatants. How-
ever spleen cell supernates of T -depleted rats do not 
contain the activity. Further, maximal inhibitor concen-
trations are obtained in the first 2 days of culture when 
more than 65% of cultured cells are large blasts actively 
synthesizing protein. As the number of actively metab-
olizing blast cells decrease in subsequent days of culture 
inhibitor concentration falls. Finally thymocytes of rats 
pretreated with hydrocortisone acetate, to deplete thy-
mus cortex cells are unable to secrete inhibitor in cul-
ture. 
These findings reveal that the cells producing inhibi-
tory DNA synthesis in an animal made tolerant with a 
supra-optimal dose of antigen is an active blast trans-
formed T cell (present in the spleen and thymus). In the 
thymus the cell making inhibitor appears to reside in the 
thymus cortex. Previous experiments have confirmed 
that an identical cell causes nonspecific immune-sup-
pression in vitro. We suggest that this cell produces in 
vivo tolerance in antigenic competition through the 
release of inhibitor to DNA synthesis. 
Inhibitor of DNA synthesis (IDS) is a soluble, protein factor 
secreted, in vivo and in vitro, by appropriately stimulated 
lymphocytes [1]. IDS suppresses the immunologic responses of 
ant igen or mitogen-stimula ted T and B lymphocytes in vitro 
[2,3]. The immunosuppressive effect of IDS is nonspecific in 
tha t it can inhibit the response of lymphocytes to antigens a nd 
.mitogens which are diffe rent from the antigen tha t evoked its 
production [1]. Its inhibi tory action is mediated through the 
elevation of cAMP in target cells [ 4,5]. IDS has recently been 
purified t o homogeneity [6-8]. 
IDS is released in increased quantities by lymphocytes of 
rats injected intravenously with a la rge tolerogenic dose of a 
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Abbreviation : 
FCS: fetal calf serum 
IDS: inhibi tor of DNA synthesis 
LNC: lymph node cells 
OA: ovalbumin 
PHA-P: phytohemagglut inin 
soluble protein antigen eg. ovalbumin (OA) [9]. These animals 
when tested later show a lack of immunologic response not only 
to the tolerizing antigen but also to other unrelated antigens, 
ie ., they manifest nonspecific immune-suppression. This phe-
nomenon where tolerization to one antigen results in total 
immune paralysis for a short period of time is called antigenic 
competition [10]. Since IDS is produced in increased amounts 
in such animals, its nonspecific immunosuppressive activity 
might be responsible for the immunologic unresponsiveness 
seen in these animals. 
In this s tudy we have defined the lymphocyte subpopulation 
which (when appropriately stimulated) secretes IDS in the 
experimental animal model of antigenic competition. 
MATERIALS AND METHODS 
Animals 
Inbred male Lewis rats, 8-10 weeks old, purchased from Microbio-
logical Associates, Bethesda, Maryland, were used throughout. 
R eag ents 
Ovalbumin (OA) and phytohemagglutinin-P (PHA-P) were pur-
chased from Difco, Detroi t, Ml, RPM! 1640 with penicillin and strep-
tomycin from Associated Biomedics Systems, Buffalo, New York, NY 
Heat inactivated fetal calf serum (FCS) from GIBCO, Grand Island, 
New York ["H)-thymidine, [14C)-Amino Acid mix and Aquasol II from 
New England Nuclear, Boston, MA, and trypan blue from Bio Rad, 
Richmond, CA. Tissue culture flasks used were from Falcon plastics, 
Oxnard, CA, and the semi-automatic mu ltiple-well cell harvester was 
purchased from Otto Hiller Company, Madison, WI. 
A ssay for IDS A ctivity 
IDS activity was measured in each case, in crude supernatants and 
in supernatants purified to homogeneity as described previously [8). 5 
X 105 ra t lymph node cells (LNC) are cultured in each well of microwell 
culture plates containing a total volume of 0.2 ml/well consisting of 0.1 
ml of supernatants to be tested for IDS activity (see under preparation 
of supernatants), and 0.1 ml of RPMI 1640 wi th 2 J.11 / ml PHA and 10% 
FCS (final concentration) . After incubation for 44 hr at 37°C and 5% 
co~ . 1 ll Ci of 3H-thymidine (6.7 Ci;mM) is added to each well. After 
a furth er 4 hr, cells from each well are harvested onto discs of filter 
paper using the semi-automatic mu ltiple-well harvester and TCA pre-
cipitable "H counts dissolved in aquasol are determined in an Inter-
technique Liquid Scinti.llation counter. All results are expressed a an 
average of triplicate values. Standard errors of the mean are calculated 
from these values. % Inhibi tion of DNa synthesi is calculated using 
background counts (no PHA) as 100% inhibition and PHA stimulated 
(no supernatants added) 0% inhibition. 
Animal Model for Obtaining IDS Containing S upernatants 
The model used in our experiments is that of antigenic competition 
where nonspecific immune suppression by spleen cells has been previ-
ously demonstrated [11). We have already shown the production of 
IDS by spleen and thymus cells in this model [9]. Briefly, normal male 
Lewis rats were injected intravenously with a lm·ge dose of ovalbumen 
(100 mgs in 1 ml of phosphate buffered saline). Control animals received 
normal saline. 24 hr later their spleens are harvested, minced and 
filtered to remove extraneous tissue. The spleen cell suspension ob-
tained is pelleted and washed 3 times with RPMI medium. 5 X lOu 
viable nucleated spleen cells/ml were cultured in a total volume of 50 
ml of plain RPM! 1640 (no added stimulant) at 37°C in an atmosphere 
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of 5% CO" in Falcon t issue cul ture flasks. S upernatants were har vested 
at 24 hr , concentrated 20 t imes and assayed for IDS act ivity. 
Identification of Cell Secreting IDS in Above Model 
Preparation of T -depleled rats: 6-week-old male Lewis rats were 
sm gically thymectomized. One week later they were given 900 R total 
body X -radiation from a S iemans 10 kv X-ray machine and immediate ly 
reconst itu ted intravenously wi th 1 X 108 bone marrow cells (in 2 ml of 
normal saline) from normal syngeneic Lewis rats. When these rats were 
7 weeks old they were sacrificed and their bone marrow cells used to 
reconstitu te a newly thymectomized X- irradiated ba tch of syngeneic 
rats. Seven weeks later these rats were used as a source of B cells. Such 
r ats have been previously demonstrated to be completely lacking in T 
cells by the cri te ria of a bsent in vivo cell mediated immunologic 
responses and impaired response in vitro to T cell mi togens [12). 
Preparation of lymphoblast cultures: Spleen cells suspensions ob-
ta ined from the a nt igen inj ected animals were adjusted to a concentra-
t ion of 1 X 107 nucleated cells/ ml in a total volume of 15 ml and layered 
o n 10 ml of 9% Ficoll:39.9% Hypaque, 24 :10 vj v, in a sterile polypro-
py lene cent rifuge tube. After cen trifugation at 400 g fo r 20 min at 20°C 
in a n RC 5 Sorvall centrifuge, the in te rface cell were collected and 
washed 3 times. These in terface cells consist > 65% la rge blast cells as 
judged by the cri te ria of size and May-G riinwald-G iemsa staining 
characteristics [9). T he pellet of cells at the bottom of the gradient 
were also har vested washed well a nd the red cells lysed by standard 
hyp er tonic t reatment. These cells consist ma inly of medium size and 
sm all lymphocytes. 
The 2 a bove cell types were cultured separate ly as before for pro-
duction of supernatant. Supernatants were h ru·vested at 24 hr in tervals 
fo r 5 days and the cells recul tured each day in an ident ical manner. 
T he percentage of blast cells (by size a nd stain) and the viabili ty of 
cells was dete rmined prior to each recul ture. Each supernatant was 
individually purified a nd assayed for activity. 
Determination of protein. synthesis by IDS producing cells: Small 
a liquots of the blast cell were obta ined prior to each day of cul ture for 
t hese studies. 
5 X 10'' blast cells were cultured in microwell cul ture plates in a tota l 
volume of0. 1 ml RPMI 1640 with 10% FCS, at 37°C a nd 5% C02 • After 
12 hr 2.5 1-'Ci/well of [ '·'C]Amino acid mix was added fo r a fur ther 12 hr. 
The cells were then har vested using the mult iple well cell hru·vester 
a nd ['"'C)-incorporation in to TCA precipi table protein determined in a 
liquid scint illation coun ter. 
Determination of hydrocortisone sensitivity of IDS producing cell: 
R ats were pretreated wi th hydrocor t isone acetate (150 mgs/ kg body 
wt) in traperi toneally 48 hr prior to the in travenous injection of the 
lar ge dose of a ntigen. 24 hr late r the animals ru·e killed, t hymuses are 
harvested , teased and single cell suspensions of thymocytes are made. 
These ru·e then cul tured for production of supernatant as before. 
Thymuses of hydrocor t isone treated rats yielded only about 21% of 
total cells obtained from saline injected control rats. 
RESULTS 
T able I depicts the inhibitory activity in purified supernates 
of spleen cells placed in cul ture 24 h.r after injection of the large 
dose of antigen. Supernates of animals injected with ovalbumin 
produced almost complete inhibition of the DNA synthetic 
response of normal lymphocytes stimulated with PHA (83.6%) 
while spleen cells supernates of saline injected animals caused 
no inhibit ion (4.8%). 
Rats, depleted ofT cells by double thym ectomy, X-irradia-
tion and bone marrow reconstitut ion prior to injection of anti-
T A BLE I. IDS activity in punfied spleen cell supernatants" 
Supernatant source 
None 
Saline injected donor 
OA injected donor (100 mgs/ ml) 
DNA synthetic response of 
PHA stimulated normal LNC" 
"H -Tdr incorpora- Inhibi-
t ion (CPM X 10- ") tion (%) 
22,144 ± 918° 0 
21,086 ± 1068' 4.8 
5504 ± 176'" 83 .6 
"Spleen cells harvested 24 hr after donor t reatment and cultured 
without added stimula nt for 24 hr. Supernatants har vested and purified 
prior to assay. 
"Standard IDS assay system. 
c - Standard error [Background 2239 ± 96). 
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gen, and injected with ovalbumin, behave like normal animals 
injected with saline (Fig 1). Their spleen cell supernates do not 
contain inhibitory activity demonstrating the necessity of T 
cells for production of factor. 
Fig 2 shows the relationship of blast cells in cul tm e (expressed 
as a percentage of total cells) to the production of in hibitory 
activity, on successive days of culture. In the first 2 days of 
culture the presence of 65- 70% blasts in cul ture is associated 
with the secretion of m aximal concentrations of IDS. By the 
third day of reculture a decrease in IDS production is seen with 
a reduction of blasts in cultm e. On the 4th and 5th days, 
cul tm es contain very few blasts and no IDS activity is seen. 
Viability of cells was 95% on the 1st two days, > 75% o n the 3rd 
and 4th day and about 45% on the 5th day. 
Animals injected with hydrocortisone acetate 48 hr prior to 
the injection of ovalbumin show a major loss of the ability of 
their thymus cells to produce IDS (T able II) . Here supernatants 
from animals pretreated with saline cause 81.2% inhibition 
while hydrocortisone acetate treated animals have o nly 27.7% 
inhibi tory activity. Since hydrocor tisone depletes co:rtical thy-
mocytes, cortex cells appear to be responsible for IDS produc-
tion in the thymus. 
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pressed as % inhibit ion of DNA synthesis (see Materials and M ethods). 
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FIG 2. R elationship of blast cells in cul ture to production of IDS. 
Blast cells expressed as a % of total cells in cul ture. 
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TABLE II. IDS activity in purified thymus cell supernatants of 
ovalbumin injected rats 
Pretreatment of a nima ls 
Hydrocortisone acetate'' 
Saline'· 
ON A syntheti c response of 
PHA st imu lated norma l LNC" 
"H-Tdr incorpo-
ration (CPM x Inhi bition (% ) 
10-") 
18,436 27.7 
4,794 81.2 
" Standard IDS assay system. 
" Hydrocortisone acetate (150 mg/kg) i.p. , 48 hr prior to OA injection. 
,. Saline injected-same manner as b. 
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F IG 3. Relationship of IDS production to protein synthetic activity 
of cells in culture. Protein synthesis expressed at [ '"C)Amino Acid 
incorporation into cells. 
Finally Fig 3 demonstrates that IDS production is maximal 
wh en the cells in culture are actively synthesizing protein . 
Protein synthesis is measured as [ 14C]Amino acid incorporation 
into cells. High inhibito.ry activity is seen on the fJrst two days 
of culture when the cells are metabolically very active. As 
activity falls off fTom the third day onwards production of IDS 
decreases. 
DISCUSSION 
We have previously shown that IDS secretion by spleen cells 
of rats injected with a tolerizing dose of antigen occurs 24 hr 
after injection of antigens [9]. At this time the animal shows 
evidence of total immunologic unresponsiveness, thereby ex-
hibiting the phenomenon of antigenic competition. We have 
also demonstrated that the subpopulation of cells releasing IDS 
in these immunologically paralyzed animals are adherent to 
glass [9]. Experiments by Bash and Waksman revealed that the 
cells causing this immune suppression were not macrophages 
[11]. 
Circumstant ial evidence from earlier work had suggested that 
the cells making IDS were thymus-derived, ie., T cells. This 
premise was based on the fact that IDS was made by lympho-
cytes stimulated with a T cell mitogen, eg. , Con A and that 
thymus cells, with appropriate stimulation, could secrete IDS 
[1,9]. In our present studies in the model of antigenic competi-
tion we have shown that spleen cells of animals depleted of only 
T cells, by experimental manipulation, are unable to make IDS. 
T his find ing adds confirmatory direct evidence to the previous 
implication that IDS is produced by T cells. A further finding 
was that maximal concentration of IDS was secreted 24 to 48 
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hr after in vivo stimulation, when the major proportion of ficoll-
hypaque separated spleen cells in culture were large prolifer-
ating blasts. IDS production dropped off with a decrease in the 
number of blast cells in culture. We also found that thymocytes 
of these animals which normally secreted IDS 24 hr after the 
antigenic stimulus (like spleen cells) were unable to produce 
IDS if the a nimals were pretreated with hydrocortisone acetate 
which depletes cortical thymocytes. The above findings suggest 
the conclusion that a T cell su bpopulation present in the spleen 
and th ymus is capable of secreting IDS following an appropriate 
antigenic stimulus. In the thymus this IDS producing cell 
resides in the cortex of the gland. Morphologically the IDS 
secreting cell is a large blast. 
Previous in vitro lymphocyte studies by Raff and Cantor [13] 
in mice demonstrated that nonspecific immune suppression was 
produced by T cells present in the thymus and spleen . Stutman 
[14] showed that the splenic cells causing this suppression were 
large blastoid T 1 cells, ie., T cells which had not acquired the 
8 (theta) swface marker. T , cells are normally not found in the 
peripheral circulation since T cells prior to entering the periph-
ery migrate from the thymus cortex through the thymus me-
dulla, where they acquire the 8 (theta) antigen. Goldschneider 
[15] working with rats has shown that there is an alternate 
pathway of migration for T cells, directly fro m the thymus 
cortex to the spleen without passing through the medulla . 
Nonspecific suppressor T cells may migrate via this route . Our 
in vivo experiments in an animal model with nonspecific im-
mune suppression show that the cell secreting IDS appears to 
be identical to the cell t hat has previously been shown to cause 
nonspecific suppression in vitro . Since IDS causes nonspecific 
inhibition of lymphocyte function it is possible that in these 
animals the immunologic tolerance is caused by IDS secreted 
by these suppressor cells. 
A final finding was that IDS release into supernates occurred 
while the cells in culture were actively synthesizing protein. As 
protein synthesis decreased in subsequent days of cul ture IDS 
production diminished. However IDS was not produced in 
supernatants collected earlier than 20 hr of initial cul ture al-
though active protein synthesis occurred and continued as early 
as 4-6 hr (data no t shown) . These findings suggest that IDS 
production requires live actively functioning cells. IDS there-
fore is not a product released passively by a dead or dying cell . 
Further, IDS release occurs later in the cell cycle, ie., in the 
stage of protein synthesis occurring just lJI'ior to or closely 
associated with DNA synthesis. This delayed release of IDS is 
very typical for the time sequence when the "immunoregula-
tory" lymphokines are usually produced in supernates. 
In conclusion we have demonstrated that in animals with 
experimentally induced immune paralysis, IDS (an immuno-
suppressive lymphokine) is secreted by a unique subset of active 
T cells which are present in the thymus cortex and the spleen. 
These cells when appropriately stimulated secrete IDS which 
might be responsible for the immune suppression seen in these 
animals. 
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DISCUSSION 
GREEN : Can you find and isolate this factor (IDS) in human periph-
eral blood T cells? 
JEGASOTHY : We can ma ke it us ing Con A as a stimulant. 
TURK: Have you looked at the effect of cyclophosphamide treatment 
on your system in rats? 
JEGASOTHY: No we have not. You can sublethally irradiate these 
animals and still get the suppressive effect in these ce lls. 
ScHILTZ: Will you comment on the tissue and species specificity of 
IDS? 
JEGASOTHY: It works on lymph node cells. It also works on L cells 
which ru·e transformed mouse fibroblasts. 
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ScHILTZ: You have tagged IDS as an inhibi tor of DNA synth esis. 
Can you in fact differentiate whether th e materia l inhibi ts DNA syn-
thesis (perhaps directly) or whether it is an inhibitor of replication, for 
which DNA synthesis is merely a measured end point? Will IDS inhibit 
DNA synthesis in vitro with DNA template, triphosphates, enzymes, 
etc? 
JEGASOTHY: We have measured the amou nt of DNA in th e cells t hat 
ar e treated with IDS a nd the amount of DNA decreased. The amount 
of DNA is the same as in unstimulated lymphocytes. 
BYSTRYN: Since your factor nonspecifically suppresses proliferation, 
do you think that conceptually it can be looked upon as a cha lone of 
lymphoid tissue? 
JEGASOTHY: You know we h ave talked about chalone being a sup-
pressive factor. We have tried to find this factor from other ce ll types, 
stimulating other cell types, getting it from epidermal homogenates 
and we cannot find the same factor. 
BRODY: Is this factor which you feel is responsible for an t igenic 
competition only locally active or can it be active systemically? We 
found, in the 60's, that antigenic competition was an entire ly localized 
phenomenon. 
JEGASOTHY: I think that looking at serum factors is very difficult in 
th e first place. I have done the same experiment you ta lked about a nd 
I cannot detect a circulat ing factor by the means we now have. 
BERMAN: Was the anti-in terferon antiserum you used anti-" immune" 
interferon or anti-"viral" in terferon? 
JEGASOTHY: We used both a nti-immune interferon and antiviral 
interferon. 
GIGLI: One wonders if this factor may bind to the ly mphocyte 
membra ne; therefore, it will no t be found in the ciTculation. 
JEGASOTHY: I think that is a great explanation a nd I think that is 
one of the reasons why many of the circulating factors cannot be 
actually found in serum. 
CLAMAN: What is the relation of IDS to blastogenic factoT? They are 
both made by activated T cells. 
JEGASOTHY: We find that the IDS comes off at a differen t fraction 
than blastogenic or mitogenic fac tors do and we aTe able to sep1p·ate 
out IDS pretty well. 
Announcement 
The Xlth International Pigment Cell Conference will be held in Sendai, Japan, Oct. 14-17, 1980. The 
scientific sessions will be comprised of special lectures, symposia and workshops on pigment cell biology 
and human and animal diseases of pigment cells including malignant melanoma and leukoderma (vitiligo). 
Full details may be obtained .by writing to Professox Makoto Seiji, Department of Dermatology, Tohoku 
University, Sendai, Japan. As in the previous 10 International Pigment Cell Conferences, there will be a 
multidisciplinary approach and pru·ticipation will include biochemists, cell biologists, basic medical 
investigators and biophysicists. 
